"Thanks to the Sontag Foundation's support, we have been able to confirm new cancer vulnerabilities that open up over 100 potential therapeutic targets across cancer types. In addition, the connections we have made through the Sontag Foundation have enabled us to begin to translate these vulnerabilities into potential therapeutics and spurred a series of collaborations resulting in new discoveries that have now been published in multiple highly cited papers."
About DSA-Funded Research
Our research team focuses on understanding the genetic changes in cancer and how these genetic changes affect cancer behavior. We have a particular focus on brain cancers, although we study many types of cancer. We have undertaken a variety of genomic approaches to profiling large numbers of cancers, including the use of SNP arrays, expression arrays, and sequencing. We have also developed several computational approaches to understand this data.
Associate Professor, Medicine, Harvard Medical School
Assistant Professor, Medical Oncology and Cancer Biology, Dana-Farber Cancer Institute
Associate Member, Cancer Program, Broad Institute of MIT and Harvard
Attending Physician, Medicine, Brigham And Women’s Hospital
University of California, Berkeley, A.B., Physics and Philosophy
University of Cambridge, M.P., Molecular Biology
University of Cambridge, Ph.D., Molecular Biology
University of California, San Francisco, M.D.
University of California, San Francisco, Internship and Residency, Internal Medicine, Molecular Medicine
Harvard Medical School/Dana-Farber Cancer Institute, Clinical Fellowship, Medical Oncology